OraQuick HIV Self-Test Arrives in Argentine Pharmacies
Laboratorios Richmond is launching the OraQuick HIV Self-Test in Argentina, marking the country’s first over-the-counter, oral-fluid HIV test designed for home use. Priced at approximately 27,500 pesos, the device detects antibodies for HIV-1 and HIV-2 from an oral swab rather than a finger-prick blood sample, according to coverage by The Nation. The test will be sold in pharmacies and online platforms, including MiTest, offering a private testing alternative aimed at addressing late-stage diagnoses in the country.
Addressing Late Diagnoses and Public Health Challenges
Health authorities point to a pressing need for early detection as roughly 140,000 people live with HIV in Argentina, while an estimated 13% remain unaware of their status. Florencia Cahn, an infectious disease specialist, noted that nearly half of new diagnoses arrive late, with 33% presenting advanced infections and opportunistic diseases. Cahn emphasized that expanding access to testing and linking patients directly to the healthcare system is critical, noting that a delayed diagnosis can be the difference between life and death.
Clinical Validation and Technical Specifications
Manufactured by the US-based OraSure Technologies, the OraQuick device yields results in 20 to 40 minutes. Manufacturer technical data indicates sensitivity and specificity rates exceeding 99% when used correctly. Maximiliano Bergman, medical director at Laboratorios Richmond, cited clinical trials including the STAR03 study across South Africa and Zimbabwe, alongside local evaluations required by the national regulator ANMAT, which demonstrated high usability and accuracy rates comparable to traditional laboratory assays.
Pricing, Distribution, and Comparison With Existing Tests
While Abbott Laboratories already markets the blood-based Panbio rapid test in Argentina, Richmond’s new product introduces the first oral-fluid, non-invasive option to pharmacy shelves and e-commerce channels.
Frequently Asked Questions About the New Oral HIV Test
Is the OraQuick self-test a definitive diagnosis?
No. As highlighted by medical experts, any reactive or positive result must be confirmed through standard laboratory blood tests at a healthcare center before any medical intervention begins.
What does a negative result mean?
A non-reactive result is only conclusive if the user has not experienced any potential exposure to the virus—such as unprotected sexual intercourse—within the preceding three months, as antibodies take time to develop.
How does the test detect the virus?
The user gently swabs the outer gums, places the device into a provided developer solution vial, and reads the results within 20 to 40 minutes by identifying antibodies against both HIV-1 and HIV-2 strains.
Keep reading